McLaren M - Search Results

1

Effect of dialyzer geometry during hemodialysis with cuprophane membranes.

Taylor JE, McLaren M, Mactier RA, Henderson IS, Stewart WK, Belch JJ. Taylor JE, et al. Among authors: mclaren m. Kidney Int. 1992 Aug;42(2):442-7. doi: 10.1038/ki.1992.307. Kidney Int. 1992. PMID: 1405328 Free article. Clinical Trial.

2

Prothrombotic effect of erythropoietin in dialysis patients.

Taylor JE, McLaren M, Henderson IS, Belch JJ, Stewart WK. Taylor JE, et al. Among authors: mclaren m. Nephrol Dial Transplant. 1992;7(3):235-9. doi: 10.1093/oxfordjournals.ndt.a092112. Nephrol Dial Transplant. 1992. PMID: 1314996

3

Effect of nifedipine on changes in fibrinogen and von Willebrand factor in haemodialysis patients treated with recombinant human erythropoietin.

Taylor JE, Belch JJ, McLaren M, Stewart WK. Taylor JE, et al. Among authors: mclaren m. Blood Coagul Fibrinolysis. 1995 Apr;6(2):100-4. doi: 10.1097/00001721-199504000-00002. Blood Coagul Fibrinolysis. 1995. PMID: 7605873

4

Effect of erythropoietin therapy and withdrawal on blood coagulation and fibrinolysis in hemodialysis patients.

Taylor JE, Belch JJ, McLaren M, Henderson IS, Stewart WK. Taylor JE, et al. Among authors: mclaren m. Kidney Int. 1993 Jul;44(1):182-90. doi: 10.1038/ki.1993.229. Kidney Int. 1993. PMID: 8355460 Free article. Clinical Trial.

5

Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers.

Bridges AB, Fisher TC, Scott N, McLaren M, Belch JJ. Bridges AB, et al. Among authors: mclaren m. Free Radic Res Commun. 1992;16(2):89-97. doi: 10.3109/10715769209049162. Free Radic Res Commun. 1992. PMID: 1628859

6

Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon.

Lau CS, McLaren M, Belch JJ. Lau CS, et al. Among authors: mclaren m. Br J Rheumatol. 1991 Dec;30(6):433-6. doi: 10.1093/rheumatology/30.6.433. Br J Rheumatol. 1991. PMID: 1747698

7

The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy.

Jennings PE, McLaren M, Scott NA, Saniabadi AR, Belch JJ. Jennings PE, et al. Among authors: mclaren m. Diabet Med. 1991 Nov;8(9):860-5. doi: 10.1111/j.1464-5491.1991.tb02125.x. Diabet Med. 1991. PMID: 1837513

8

The effects of thromboxane receptor blockade on platelet aggregation and digital skin blood flow in patients with secondary Raynaud's syndrome.

Lau CS, Khan F, McLaren M, Bancroft A, Walker M, Belch JJ. Lau CS, et al. Among authors: mclaren m. Rheumatol Int. 1991;11(4-5):163-8. doi: 10.1007/BF00332555. Rheumatol Int. 1991. PMID: 1838424 Clinical Trial.

9

The pharmacological effects of cicaprost, an oral prostacyclin analogue, in patients with Raynaud's syndrome secondary to systemic sclerosis--a preliminary study.

Lau CS, McLaren M, Saniabadi A, Scott N, Belch JJ. Lau CS, et al. Among authors: mclaren m. Clin Exp Rheumatol. 1991 May-Jun;9(3):271-3. Clin Exp Rheumatol. 1991. PMID: 1879086 Clinical Trial.

10

Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers.

Bridges AB, McLaren M, Saniabadi A, Fisher TC, Belch JJ. Bridges AB, et al. Among authors: mclaren m. Blood Coagul Fibrinolysis. 1991 Jun;2(3):447-52. doi: 10.1097/00001721-199106000-00007. Blood Coagul Fibrinolysis. 1991. PMID: 1932530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters